INS and diabetic kidney disease: Among the PPAR isoforms, PPAR-γ activation has been shown to improve insulin sensitivity, reduce renal inflammation, and inhibit profibrotic signaling, thereby attenuating glomerulosclerosis and tubulointerstitial fibrosis in DKD (56).